ABOUT THE COMPANY
WORD OF WELCOME FROM THE DIRECTOR
Dear colleagues and partners,
I am the General Director of BEBIG LLC and welcome you to our website!
Our company was founded in July 2004 in order to introduce high-tech and innovative cancer treatment methods to the Russian market. By 2006, we were already supplying life-saving microsources for the treatment of prostate cancer using low-dose brachytherapy in Russia. In 2014, the first plant in Russia for the production of I-125 microsources opened. One of Bebig’s key priorities is to promote brachytherapy as a high-tech method for prostate cancer treatment.
Our main mission is to improve the quality of men's lives and promote a healthy lifestyle. BEBIG actively supports the development of the medical services and medical equipment market in order to ensure that people have access to high-tech and effective treatments. Our company supports the development of the nuclear medicine infrastructure in Russia to fight against socially significant diseases. Nuclear medicine will not only greatly reduce cancer mortality, but also take the country’s medical services to a new level.
Currently, BEBIG is present in 29 medical centres across Russia. We have also entered the markets of Kazakhstan and Armenia. The company actively supports research and development in key areas for modern cancer treatment methods, advanced doctor training and population screening. We do everything we can to treat patients at the highest professional level, taking into account their needs and expectations.
We look forward to working with you!
History of the company
Achievements of the company
IODINE-125 MICROSOURCES FOR THE TREATMENT OF PROSTATE CANCER
What are IODINE-125 MICROSOURCES?
The BEBIG production of iodine-125 microsources
Description of IODINE-125 MICROSOURCES
MICROSPHERES FOR THE TREATMENT OF LIVER CANCER
Nanostructured yttrium-90 microspheres
Developed stages of R&D